November 18, 2026
Daily Health News: November 18, 2026
By Ryan Purakal
Three stories worth knowing today, and what they mean for you.
1. It's official: the U.S. has lost its measles-free status
On Tuesday, Nov. 17, the Pan American Health Organization (PAHO), the World Health Organization's office for the Americas, announced that measles is once again spreading locally in the United States, Mexico and Bolivia. That means all three countries have lost their measles elimination status. The U.S. had held that status since 2000. A country loses it when the same strain keeps circulating for 12 months or more.
The latest CDC count shows 5,412 measles cases in the U.S. so far this year, and state health departments have reported 10 deaths, according to ABC News. For comparison, the country had fewer than 300 cases in 2024. Across the whole region, PAHO counted 58,213 confirmed cases and 82 deaths as of Nov. 13, compared with 12,806 cases in the same period last year. PAHO says every community needs at least 95% of people to have both doses of the measles vaccine, and warns that a good national average can hide places where coverage is low. U.S. health officials say they will work to win the status back.
What to do: The CDC says two doses of the MMR vaccine are 97% effective at preventing measles. If you're not sure you got both doses, ask your doctor's office or pharmacist to check your records.
2. Some kids are stuck living in hospitals because they have nowhere safe to go
A KFF Health News investigation published Nov. 18 looks at "boarding," when children stay in a hospital after they no longer need medical care because there's no safe home or placement ready for them. It follows Jaloni, who was 14 when he was shot in 2023 and now uses a wheelchair. Over three years he spent more than 475 days at SSM Health Cardinal Glennon Children's Hospital in St. Louis, and part of that time was because he had nowhere safe to be discharged to. He became a ward of Illinois, his grandmother died while he was in the hospital, and his aunt later became his foster parent and found a first-floor apartment with a ramp. He went home in May and is now 18.
He is far from the only one. Missouri had 648 young people in state custody boarded in hospitals in the fiscal year that ended in June, and the state spent more than $64.7 million over five years on boarding kids in its custody. In Illinois, 304 young people stayed in psychiatric hospitals longer than medically needed in the year ending June 2025, and another 312 waited more than 24 hours in emergency rooms for a safe placement. A shortage of foster homes that can care for kids with mental health conditions, chronic illnesses or disabilities is a big part of the problem. Missouri lawmakers have tried several times to end the practice, but no bill has passed.
What to do: If you or someone you know is in foster care or in the hospital waiting on a placement, it is okay to ask questions. Ask the caseworker or the hospital social worker what the discharge plan is and how long it is expected to take.
Source: KFF Health News
3. A big trial tested a weight-loss drug in teens: strong results, plus side effects
A study published in the journal JAMA tested tirzepatide, a once-a-week injected medicine, in 160 teenagers ages 12 to 17 with obesity at 31 centers in six countries. Everyone also got help with healthy lifestyle changes. After 72 weeks, teens on the drug lowered their BMI by 18.5% on average, while the placebo group's BMI rose by 0.5%. More than half of the teens on tirzepatide dropped below the BMI cutoff for obesity, compared with 7.1% on placebo. Blood pressure, cholesterol and blood sugar also improved, and growth and puberty looked similar in both groups.
Side effects were common. About 81.5% of teens on the drug had stomach problems like nausea, vomiting or diarrhea, mostly mild or moderate, and 9.3% stopped because of side effects, compared with none on placebo. Depression or suicidal thoughts were reported as side effects in 4.6% of the tirzepatide group and 2.0% of the placebo group, none of them serious. The trial was paid for by Eli Lilly, the company that makes the drug, and the company helped design and analyze it. Tirzepatide is already approved for adults with obesity, while two similar drugs are already approved for teens.
What to do: Any weight-loss medicine is a decision to make with a doctor who knows your health history, not something to get from social media or online sellers. If you're feeling overwhelmed or having thoughts of hurting yourself, call or text 988 any time to reach the Suicide and Crisis Lifeline.
Source: News-Medical
Health Decoded's daily news roundup pulls from public reporting and puts it in plain language. It isn't medical, legal, or financial advice.